Seventure’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Seventure focuses on early to high growth life sciences, information technology and communication sectors. Read more

Isabelle De Cremoux's photo - CEO of Seventure

CEO

Isabelle De Cremoux

CEO Approval Rating

68/100

Founded:

1997

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Midi Capital is perceived as one of Seventure's biggest rivals. Midi Capital's headquarters is in Toulouse, Other, and was founded in 2002. Midi Capital operates in the Software Asset Management industry. Midi Capital generates 118% of Seventure's revenue.

Isai has been one of Seventure's top competitors. Isai is a Private company that was founded in 2008 in Paris, Other. Isai operates in the Diversified Investment Services industry. Compared to Seventure, Isai has 40 more employees.

123Venture is Seventure's #3 rival. 123Venture was founded in Paris, Other} in 2001. 123Venture is in the Investment Banking & Brokerage industry. Compared to Seventure, 123Venture generates $15M more revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Idinvest Partners a competitor of Seventure?

Acquisitions

No recent acquisitions found related to Seventure

Seventure Funding History

$176M$205.5M$431M$665M

Since Seventure was founded in 1997, it has participated in 4 rounds of funding. In total Seventure has raised $665.0M. Seventure's last funding round was on Aug 2020 for a total of $234.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Investment Fund
Aug 2020
$234M
-
Investment Fund
Mar 2019
$225.5M
-
Investment Fund
Mar 2018
$29.5M
-
Unattributed
Dec 2015
$176M

Novartis Pharma AG

Total Funding: $665M

Since Seventure was founded in 1997, it has participated in 4 rounds of funding. In total Seventure has raised $665.0M. Seventure's last funding round was on Aug 2020 for a total of $234.0M

Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Galecto is a biotechnology firm that develops novel small molecule therapeutics for the treatment of fibrosis and cancer.
$64M
Sep 24, 2020
Equity
Nov 01, 2014
Siolta Therapeutics is a biotechnology company that develops and commercializes microbiome-based therapies for the treatment of chronic diseases.
$30M
Sep 21, 2020
Series B
-
clim8 develops a thermal platform that offers skin temperature monitoring, analyzing and regulating solutions to the connected textiles market.
$3.2M
Jul 26, 2020
Series A
-
Tubulis is a biotechnology company that develops antibody-drug conjugates for the treatment of cancer.
$12.2M
Jul 20, 2020
Series A
-
Citryll is a pharmaceutical firm that researches, develops and commercializes therapeutics for the treatment of NETosis and NETs.
$20.8M
Jul 01, 2020
Venture Round
-

Seventure News

August 12, 2020Leaders League

PME Investimentos and Seventure invest in LiMM Theraputics

Portugal-headquartered PME Investimentos and France's Seventure Partners have completed a co-investme... See more »
August 4, 2020Fibre2Fashion

Clim8 generates 2.75 million

August 3, 2020Nutrition Insight

Seventure scores millions in funding for microbiome start-up innovation

03 Aug 2020 --- European venture company Seventure Partners has revealed that the French government h... See more »
July 29, 2020tech_eu

French wearable technology startup Clim8 raises 2.75 for patented heat-regulating textiles

Clim8, a French wearable technology startup, has raised €2.75 million from Agileo Ventures, the Devea... See more »
July 28, 2020Inside Composites

French innovator raises 2.75m for growth and NPD

Clim8, the young innovative company from Lyon, France, has just completed a financing round that rais... See more »
July 21, 2020FinSMEs

Tubulis Raises 10.7M in Series A Funding

Tubulis, a Munich, Germany-based developer of protein-drug conjugates, closed a €10.7m Series A finan... See more »
July 2, 2020BioSpace

Citryll completes 18.5 M fundraise to develop CIT-013, an antibody targeting Neutrophil Extracellular Traps

Citryll announced it closed a total fundraise of € 18.5 million, led by Seventure, co-led by BioGener... See more »

Seventure Press Releases

March 6, 2014PRWEB

PrestaShop Scores $9.3M in Series B Funding from XAnge Private Equity, Seventure Partners and Serena Capital to Fuel Global Expansion

PrestaShop, the world’s leading free and open source e-commerce software powering more than 165,000 o... See more »

Headquarters

5-7 rue de Monttessuy Cedex 07

Paris, Île-de-France75340

01-58-19-22-70

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Seventure focuses on early to high growth life sciences, information technology and communication sectors. Seventure was founded in 1997. Seventure's headquarters is located in Paris, Île-de-France, FR 75340. It has raised 665.0M in 4 rounds. The late...

CEO

Seventure's CEO, Isabelle De Cremoux, currently has an approval rating of 68%. Seventure's primary competitors are Midi Capital, Isai & 123Venture.

Website

seventure.fr

Frequently Asked Questions about Seventure

  1. When was Seventure founded?

    Seventure was founded in 1997
  2. Who is Seventure's CEO?

    Seventure's CEO is Isabelle De Cremoux
  3. How much revenue does Seventure generate?

    Seventure generates $10M in revenue
  4. How much funding does Seventure have?

    Seventure has historically raised $665M in funding
  5. Where is Seventure's headquarters?

    Seventure's headquarters is in Paris Île-de-France, FR
  1. How many employees does Seventure have?

    Seventure has 25 employees
  2. What sector does Seventure operate in?

    Seventure is in Diversified Investment Services
  3. Who are Seventure's competitors?

    Seventure's top competitors are Midi Capital, Isai, 123Venture
  4. Who has Seventure invested in?

    Seventure's has invested in companies such as Galecto, Siolta Therapeutics, clim8